Beta-D-glucan (BDG), a polysaccharide in various organisms’ cell walls, serves as a biomarker for fungal infections, notably invasive ones like candidiasis and aspergillosis. Elevated BDG levels in blood suggest such infections. Testing is common in high-risk patients undergoing immunosuppressive therapy to detect fungal infections.